Search Page

1

Cite

Share

In Vitro Inhibitory Effects of Sesamin on CYP4F2 Activity.

Watanabe H, Yamaori S, Kamijo S, Aikawa K, Ohmori S. Watanabe H, et al. Among authors: yamaori s. Biol Pharm Bull. 2020;43(4):688-692. doi: 10.1248/bpb.b19-00953. Biol Pharm Bull. 2020. PMID: 32238710 Free article.

Cite

Share

2

Cite

Share

Effects of acid and lactone forms of statins on S-warfarin 7-hydroxylation catalyzed by human liver microsomes and recombinant CYP2C9 variants (CYP2C9.1 and CYP2C9.3).

Shiozawa A, Yamaori S, Kamijo S, Ohmori S. Shiozawa A, et al. Among authors: yamaori s. Drug Metab Pharmacokinet. 2021 Feb;36:100364. doi: 10.1016/j.dmpk.2020.10.003. Epub 2020 Oct 29. Drug Metab Pharmacokinet. 2021. PMID: 33341662

Cite

Share

3

Cite

Share

Expression profile of cytochrome P450s and effects of polycyclic aromatic hydrocarbons and antiepileptic drugs on CYP1 expression in MOG-G-CCM cells.

Ozawa S, Yamaori S, Aikawa K, Kamijo S, Ohmori S. Ozawa S, et al. Among authors: yamaori s. Life Sci. 2020 Oct 1;258:118140. doi: 10.1016/j.lfs.2020.118140. Epub 2020 Jul 27. Life Sci. 2020. PMID: 32730838

Cite

Share

4

Cite

Share

In vitro inhibition of CYP2C9-mediated warfarin 7-hydroxylation by iguratimod: possible mechanism of iguratimod-warfarin interaction.

Yamaori S, Takami K, Shiozawa A, Sakuyama K, Matsuzawa N, Ohmori S. Yamaori S, et al. Biol Pharm Bull. 2015;38(3):441-7. doi: 10.1248/bpb.b14-00711. Epub 2015 Jan 19. Biol Pharm Bull. 2015. PMID: 25757926 Free article.

Cite

Share

5

Cite

Share

Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine.

Ikemura N, Yamaori S, Kobayashi C, Kamijo S, Murayama N, Yamazaki H, Ohmori S. Ikemura N, et al. Among authors: yamaori s. Chem Biol Interact. 2019 Jun 1;306:1-9. doi: 10.1016/j.cbi.2019.04.005. Epub 2019 Apr 6. Chem Biol Interact. 2019. PMID: 30965050

Cite

Share

6

Cite

Share

Lack of epithelial PPARγ causes cystic adenomatoid malformations in mouse fetal lung.

Kim JH, Yamaori S, Tanabe T, Takagi M, Matsubara T, Okamoto M, Kimura S, Gonzalez FJ. Kim JH, et al. Among authors: yamaori s. Biochem Biophys Res Commun. 2017 Sep 16;491(2):271-276. doi: 10.1016/j.bbrc.2017.07.113. Epub 2017 Jul 21. Biochem Biophys Res Commun. 2017. PMID: 28739257 Free PMC article.

Cite

Share

7

Cite

Share

Implication of intestinal VDR deficiency in inflammatory bowel disease.

Kim JH, Yamaori S, Tanabe T, Johnson CH, Krausz KW, Kato S, Gonzalez FJ. Kim JH, et al. Among authors: yamaori s. Biochim Biophys Acta. 2013 Jan;1830(1):2118-28. doi: 10.1016/j.bbagen.2012.09.020. Epub 2012 Oct 2. Biochim Biophys Acta. 2013. PMID: 23041070 Free PMC article.

Cite

Share

8

Cite

Share

Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19.

Jiang R, Yamaori S, Okamoto Y, Yamamoto I, Watanabe K. Jiang R, et al. Among authors: yamaori s. Drug Metab Pharmacokinet. 2013;28(4):332-8. doi: 10.2133/dmpk.dmpk-12-rg-129. Epub 2013 Jan 15. Drug Metab Pharmacokinet. 2013. PMID: 23318708 Free article.

Cite

Share

9

Cite

Share

Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once-daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation.

Mimura A, Yamaori S, Ikemura N, Katsuyama Y, Matsuzawa N, Ohmori S. Mimura A, et al. Among authors: yamaori s. J Clin Pharm Ther. 2019 Aug;44(4):565-571. doi: 10.1111/jcpt.12834. Epub 2019 Apr 4. J Clin Pharm Ther. 2019. PMID: 30950099

Cite

Share

10

Cite

Share

A Specific Probe Substrate for Evaluation of CYP4A11 Activity in Human Tissue Microsomes and a Highly Selective CYP4A11 Inhibitor: Luciferin-4A and Epalrestat.

Yamaori S, Araki N, Shionoiri M, Ikehata K, Kamijo S, Ohmori S, Watanabe K. Yamaori S, et al. J Pharmacol Exp Ther. 2018 Sep;366(3):446-457. doi: 10.1124/jpet.118.249557. Epub 2018 Jul 5. J Pharmacol Exp Ther. 2018. PMID: 29976573

Cite

Share